Relpax 2016 U.S. Promotional Audit Report

July 2017 •
24 pages •
Report ID: 5210600 •
Format: PDF

Summary
Table of contents

The 5 Key Questions Addressed by this Report:
• How many physicians were reached by Relpax through personal promotion in 2016 and how does this compare to its peer set in the Migraine markets?
• What promotional mix was leveraged (e.g., sales rep detailing, physician education, and paid speaking) and what was the median spend on each type of activity?
• How does Pfizer’s depth of coverage vary within key specialties (e.g., Family Medicine, Neurology, Internal Medicine, and Psychiatry) and how does this compare to its peers and the overall set of rep-accessible physicians?
• How often are physicians receiving paid meals for Relpax throughout the year (e.g., monthly, quarterly, annually)?
• Who were the most detailed prescribers and top paid speakers for Relpax in 2016?

Data Sources and Methodology:
• MDDetails leverages company-reported financial transaction data disclosed through CMS Open Payments. This data set captures all transfers of value (e.g., speaking fees, consulting fees, travel, education, and meals) made on behalf of a drug or device manufacturer to a physician. Currently, 42 months of longitudinal data is available – covering payments to more than 900,000 U.S. healthcare professionals.
• Over 5,400 paid interactions across 2,600 physicians made on behalf of Relpax were carefully examined to support our analysis. In addition, interaction data from 9 peer products (e.g. Botox, Bupap, Cambia, Onzetra Xsail, Sumavel Dosepro, Treximet, Zecuity, Zembrace, and Zomig ) was leveraged to provide benchmarking and market insights.

Ahmad helps you find the right report:

+1 718 618 4302
Contact by email

FAQ

Testimonials

The market research advisor answered my questions quickly and professionally. ReportBuyer's team did their best to ensure that I felt comfortable before making the investment to purchase the report.

Cristian Nunez

Director of Corporate Development Chugach Alaska Corporation

My overall experience with ReportBuyer today has been very positive, and I must thank you for your patience (...). Also, the sample you sent me and the explanations provided were very helpful.

D. Lescuyer

Executive Vice President Oral Business at Skyepharma

The research specialist was very helpful, and proposed the best content for my needs. ReportBuyer also offered a great follow-up, thanks for everything !

P. Thompson

EMEA Managing Director

We were satisfied with the support that ReportBuyer's team provided. Thanks to their recommendations, the report we purchased provided exactly what we want.

Y. Wang

Business Analyst

We didn't have time to do the research internally, and thanks to ReportBuyer's team we were able to find the appropriate data.

S. Chen

Research Coordinator

I was impressed by the customer service: it was fast, responsive, and 100% professional !

D. Krivan

Market Research Analyst

The research specialist provided prompt and helpful service. He also followed up to ensure I had all the information to deliver my business development plan.

C. Adams

Senior Business Development Manager